<code id='54AA94832E'></code><style id='54AA94832E'></style>
    • <acronym id='54AA94832E'></acronym>
      <center id='54AA94832E'><center id='54AA94832E'><tfoot id='54AA94832E'></tfoot></center><abbr id='54AA94832E'><dir id='54AA94832E'><tfoot id='54AA94832E'></tfoot><noframes id='54AA94832E'>

    • <optgroup id='54AA94832E'><strike id='54AA94832E'><sup id='54AA94832E'></sup></strike><code id='54AA94832E'></code></optgroup>
        1. <b id='54AA94832E'><label id='54AA94832E'><select id='54AA94832E'><dt id='54AA94832E'><span id='54AA94832E'></span></dt></select></label></b><u id='54AA94832E'></u>
          <i id='54AA94832E'><strike id='54AA94832E'><tt id='54AA94832E'><pre id='54AA94832E'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          explore

          author:focus    - browse:728
          Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT
          National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

          WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

          “If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

          advertisement

          A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus